Literature DB >> 23839771

Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.

Emma J Rose1, Derek W Morris, April Hargreaves, Ciara Fahey, Ciara Greene, Hugh Garavan, Michael Gill, Aiden Corvin, Gary Donohoe.   

Abstract

The single nucleotide polymorphism rs10503253 within the CUB and Sushi multiple domains-1 (CSMD1) gene on 8p23.2 has been identified as genome-wide significant for schizophrenia (SZ). This gene is of unknown function but has been implicated in multiple neurodevelopmental disorders that impact upon cognition, leading us to hypothesize that an effect on brain structure and function underlying cognitive processes may be part of the mechanism by which CMSD1 increases illness risk. To test this hypothesis, we investigated this CSMD1 variant in vivo in healthy participants in a magnetic resonance imaging (MRI) study comprised of both fMRI of spatial working memory (N = 50) and a voxel-based morphometry investigation of grey and white matter (WM) volume (N = 150). Analyses of these data indicated that the risk "A" allele was associated with comparatively reduced cortical activations in BA18, that is, middle occipital gyrus and cuneus; posterior brain regions that support maintenance processes during performance of a spatial working memory task. Conversely, there was an absence of significant structural differences in brain volume (i.e., grey or WM). In accordance with previous evidence, these data suggest that CSMD1 may mediate brain function related to cognitive processes (i.e., executive function); with the relatively deleterious effects of the identified "A" risk allele on brain activity possibly constituting part of the mechanism by which CSMD1 increases schizophrenia risk.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CSMD1; fMRI; schizophrenia; voxel-based morphometry (VBM); working memory

Mesh:

Substances:

Year:  2013        PMID: 23839771     DOI: 10.1002/ajmg.b.32182

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  13 in total

1.  Systems genetics analysis of pharmacogenomics variation during antidepressant treatment.

Authors:  M B Madsen; L J A Kogelman; H N Kadarmideen; H B Rasmussen
Journal:  Pharmacogenomics J       Date:  2016-10-18       Impact factor: 3.550

Review 2.  A Genome-Wide Association Study in isolated populations reveals new genes associated to common food likings.

Authors:  Nicola Pirastu; Maarten Kooyman; Michela Traglia; Antonietta Robino; Sara M Willems; Giorgio Pistis; Najaf Amin; Cinzia Sala; Lennart C Karssen; Cornelia Van Duijn; Daniela Toniolo; Paolo Gasparini
Journal:  Rev Endocr Metab Disord       Date:  2016-06       Impact factor: 6.514

Review 3.  Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia.

Authors:  Aristotle N Voineskos
Journal:  Schizophr Res       Date:  2014-06-02       Impact factor: 4.939

4.  Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working Memory.

Authors:  Donna Cosgrove; Omar Mothersill; Kimberley Kendall; Bettina Konte; Denise Harold; Ina Giegling; Annette Hartmann; Alex Richards; Kiran Mantripragada; Michael J Owen; Michael C O'Donovan; Michael Gill; Dan Rujescu; James Walters; Aiden Corvin; Derek W Morris; Gary Donohoe
Journal:  Neuropsychopharmacology       Date:  2017-06-13       Impact factor: 7.853

Review 5.  Imaging genetics and psychiatric disorders.

Authors:  R Hashimoto; K Ohi; H Yamamori; Y Yasuda; M Fujimoto; S Umeda-Yano; Y Watanabe; M Fukunaga; M Takeda
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

6.  Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.

Authors:  Jana Drgonova; Donna Walther; Sulabh Singhal; Kennedy Johnson; Brice Kessler; Juan Troncoso; George R Uhl
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

7.  Schizophrenia risk variants modulate white matter volume across the psychosis spectrum: evidence from two independent cohorts.

Authors:  Viola Oertel-Knöchel; Thomas M Lancaster; Christian Knöchel; Michael Stäblein; Helena Storchak; Britta Reinke; Alina Jurcoane; Jonathan Kniep; David Prvulovic; Kiran Mantripragada; Katherine E Tansey; Michael C O'Donovan; Michael J Owen; David E J Linden
Journal:  Neuroimage Clin       Date:  2015-03-13       Impact factor: 4.881

8.  Identification of NCAN as a candidate gene for developmental dyslexia.

Authors:  Elisabet Einarsdottir; Myriam Peyrard-Janvid; Fahimeh Darki; Jetro J Tuulari; Harri Merisaari; Linnea Karlsson; Noora M Scheinin; Jani Saunavaara; Riitta Parkkola; Katri Kantojärvi; Antti-Jussi Ämmälä; Nancy Yiu-Lin Yu; Hans Matsson; Jaana Nopola-Hemmi; Hasse Karlsson; Tiina Paunio; Torkel Klingberg; Eira Leinonen; Juha Kere
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

Review 9.  Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.

Authors:  James N Samsom; Albert H C Wong
Journal:  Front Psychiatry       Date:  2015-02-18       Impact factor: 4.157

10.  Genetic Variants in CSMD1 Gene Are Associated with Cognitive Performance in Normal Elderly Population.

Authors:  Vadim Stepanov; Andrey Marusin; Kseniya Vagaitseva; Anna Bocharova; Oksana Makeeva
Journal:  Genet Res Int       Date:  2017-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.